iStreet Network Ltd.
Snapshot View

2.40 +0.02 ▲0.8%

05 August 2021, 04:00:00 P.M.
Volume: 1,412

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.istreetnetwork.com, www.istreetbazaar.com
Financial Indicators
Market Cap 5.11 Cr.
Earnings per share (EPS) -0.05 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 32.75 Trailing Twelve Months Ending 2021-03
Book Value / Share -0.99 Trailing Twelve Months Ending 2021-03
Price to Book Value -2.43 Calculated using Price: 2.40
Dividend Yield 0.00 Period Ending 2020-03
No. of Shares Subscribed 2.13 Cr. 21,300,000 Shares
FaceValue 4
Company Profile

iStreet Network started as a small trading firm in 1988. It set up a medium size WHO standard ‘Specialty Chemicals & Pharmaceuticals’ manufacturing company in the year 1994. It performed highly complex chemistry at the plant like Bromination, Nitration, Acylation, Esterification, Reduction, Hydrolysis (Alkali Fusion), Friedel Craft’s Reaction, Grignard Reaction etc. The company was manufacturing Beta Blockers and Intermediates of ACE Inhibitors at different locations in Gujarat and Maharashtra.

In mid 1998, it promoted India’s first electronic, neutral ‘Chemical Exchange’. A strategic alliance was signed with Price Waterhouse Cooper with equity participation. The exchange has extensive reach to over 4,000 participants globally and over a billion dollar deals were posted on the exchange. It exited B2B Chemical Exchange business in 2002. In 2014, the company got into B2C eCommerce - Internet Retail and exited Pharmaceutical & Intermediate business. The project is called ‘iStreet Bazaar’.

iStreet Bazaar was selected part of the Alpha Program at the Web Summit 2014 in Dublin - one of the world’s most influential and international technology events. iStreet Bazaar gave a perspective of how common man has consumed and adopted technology for his good. The Project also got recognition from various organizations and publications like ‘Start up Project of the year 2014’ by Silicon India, ‘10 Fastest Growing Company 2016’ by Silicon Review, ‘Top 30 Fastest Growing Companies 2016 to Watch’ by Silicon Review, ‘10 Fastest Growing Retail Company’ by Insight Success.

Business area of the company

The company is in the business of Internet Retailing - fusion of online and offline called ‘Internet Retail’. Internet Retail can be understood as a retail with ‘physical retail store which runs on virtual inventory’. The company is empowering lakhs of Mom & Pop Retail stores with this Internet Retail format - iStreet Bazaar Stores across India which can be accessed by any one (common people of India) anywhere which enables them to buy products and services available online. The Company is categorized as ‘Internet & Retail Catalogue’ by the Bombay Stock Exchange.

Businesses

  • Internet Retial
  • B2B Wholsale
  • Direct to Consumer

Awards and Milestones

  • ‘Startup project of the year’ by Silicon India in November 2014
  • ‘10 fastest Companies’ by Silicon Review in February 2016
  • ‘10 fastest growing Retail Company’ by Insight Success in September 2016
  • ‘Top 30 fastest Companies to watch’ by Silicon Review in December 2016

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
+0.84%
1 Week
+1.69%
1 Month
+6.19%
3 Month
+62.16%
6 Month
+5.26%
1 Year
+22.45%
2 Year
+16.50%
5 Year
-89.81%
9 years 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03
Return on Equity (%) -173.79 5.18 -1.37 -12.67 -72.30 -182.35
Return on Capital Employed (%) -173.79 5.18 -1.37 -11.96 -67.73 -134.98 -266.50
Return on Assets (%) -5.07 4.65 -1.26 -10.44 -55.72 -98.99 -111.40 -58.42 -17.39

Balance Sheet View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Shh. Funds 1 5 5 5 4 0 -2 -2 -2
Non Curr. Liab. 0 1 2 2 2
Curr. Liab. 0 0 1 1 1 1 1 1 1
Minority Int.
Equity & Liab. 1 5 5 6 5 3 1 0 0
Non Curr. Assets 1 1 1 1 1 0 0 0 0
Curr. Assets 0 4 4 5 4 2 1 0 0
Misc. Exp. not W/O
Total Assets 1 5 5 6 5 3 1 0 0

Profit Loss View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Net Sales 0 0 0 1 18 35 0 2
Other Income 0 0 3 0 0 0 0
Total Income 0 1 1 4 19 35 0 2
Total Expenditure 0 0 -1 -4 -21 -38 -1 -2 0
PBIDT 0 0 0 0 -3 -3 0 0 0
Interest 0 0
Depreciation 0 0 0 0 0 0 0 0
Taxation
Exceptional Items -2
PAT 0 0 0 -1 -3 -4 -2 0 0

Cash Flow View Details

Particulars 9 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr.
Cash Fr. Operatn. 0 -2 0 -3 -3 -2 0 0 0
Cash Fr. Inv. -2 0 3 0 0 0 0
Cash Fr. Finan. 3 0 3 2 0 0
Net Change 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 46.20 46.20 46.20 46.20 46.20 46.20 46.20 46.20 46.20
Public 53.80 53.80 53.80 53.80 53.80 53.80 53.80 53.80 53.80
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Mon, 02 Aug 2021
Intimation About Annual Internal Audit Report Of Our RTA Adroit Corporate Services Private Ltd
We would like to submit the Annual Internal Audit report of our RTA Adroit Corporate Services Private Ltd for the period 01st April 2020 to 31st March 2021.
Mon, 26 Jul 2021
Declaration Or Statement Of Impact Of Audit Qualifications
Attached is the declaration or Statement of Impact of Audit Qualifications with respect to Auditors Report on Standalone Financial Results of the Company for the quarter and year ended March 31 2021 is an unmodified opinion. In this regard please find declaration in Annexure A.
Kindly ignore the previous declaration filed by the company for Declaration or Statement of Impact of Audit Qualifications
We request you to kindly take note of the above in your records.
Thu, 22 Jul 2021
Declaration Or Statement Of Impact Of Audit Qualifications
Attached is the declaration or Statement of Impact of Audit Qualifications with respect to Auditors Report on Standalone Financial Results of the Company for the quarter and year ended March 31 2021 is an unmodified opinion.

Technical Scans View Details

Thu, 05 Aug 2021
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Wed, 04 Aug 2021
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 188,551.74 785.85 +0.0%
Divi's Laboratories Ltd. 130,702.13 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. 79,575.04 4,783.30 +0.2%
Cipla Ltd. 76,243.85 945.20 +0.6%
Cadila Healthcare Ltd. 59,868.47 584.80 -0.5%
Piramal Enterprises Ltd. 59,065.41 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. 58,599.44 4,075.50 +0.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 31.41 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 65.87 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 45.80 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 31.70 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 28.06 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 44.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 389.73 4,075.50 +0.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-06 3.94 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 14.06 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-06 4.45 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 4.17 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 4.61 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.73 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 12.75 4,075.50 +0.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 0.18 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 0.10 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 0.35 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 1.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 9.66 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 14.13 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 18.30 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 13.08 4,075.50 +0.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 10.07 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 32.07 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 15.24 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 17.85 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 13.65 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 10.03 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 17.13 4,075.50 +0.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 32,837.50 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 19,159.59 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 15,102.20 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 11,246.80 4,075.50 +0.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2020-03 4,186.79 785.85 +0.0%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 4,923.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,783.30 +0.2%
Cipla Ltd. Consolidated 2021-03 2,401.30 945.20 +0.6%
Cadila Healthcare Ltd. Consolidated 2021-03 2,137.60 584.80 -0.5%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 2,601.15 +2.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2020-03 434.90 4,075.50 +0.2%